All Articles

A $20M round for CELYSTRA Pharma isn't just a launch; it's a strategic maneuver to solve Canada's rare disease gap and redefine Québec's role in the market.

A new fellowship award spotlights how chronic stress rewrites our immune system, pointing to a future where we might reverse a key driver of aging.

The acquisition of Pathway Capital creates a $185B giant, signaling a new phase of consolidation where scale is king and private markets open to new money.

Pampa Energía taps Halliburton in a multi-year deal to digitally transform its Vaca Muerta operations, betting on AI to unlock massive production growth.

As staffing crises cripple New England hospitals, York Hospital's partnership with ShiftMed offers a tech-driven fix. But is the gig model the ultimate cure?

A new report reveals China is systematically stealing AI capabilities, making the tech sector the world's #1 target. The very innovation driving the future is now the prize in a covert war.

A junior miner is rewriting the exploration playbook. Barranco Gold's data-driven partnership aims for systematic success in a resurgent BC gold district.

The release of a new data standard promises to break down digital silos, accelerate innovation, and power the global energy transition. Here's why it matters.

With a new hybrid, premium tech, and a higher price, Kia's redesigned Seltos isn't just an update; it's a strategic move to redefine value in a crowded segment.

Rain's new Agent Control Layer gives businesses the power to set precise spending rules for AI agents, unlocking a new era of secure, autonomous commerce.

With over half a billion in funding, Beacon is buying the small, essential businesses we rely on and supercharging them with a radical AI-native platform.

New data reveals a grim reality: Texas rural roads are nearly three times deadlier than city streets, exposing a deep infrastructure and safety crisis.

The tech-first insurer enters the Peace Garden State, betting its AI-powered app, low prices, and B-Corp mission can reshape a traditional market.

Quantified's new platform promises a future of continuous, compliant sales coaching. It's not just training; it's a bid to become the system of record.

A $95K grant fuels an innovative Chicago partnership integrating community doulas into hospitals, aiming to reverse the deadly trend of Black maternal mortality.

A new wave of AI promises to redesign health plan operations, not just automate them. We look at the systems aiming to connect a fragmented industry.

Matisse Pharmaceuticals' new sepsis drug just got a major boost from the FDA. But the real story is the invisible infrastructure—both biological and regulatory—it aims to master.

As new rules force firms to report their digital carbon footprint, a new solution from Sweep and AWS promises audit-ready data directly from the cloud.

Enveric Biosciences heads to a key UBS investor day to pitch its non-hallucinogenic antidepressant, EB-003. Can it secure the capital needed to revolutionize CNS?

With a massive discount and an activist investor on its tail, Highland Opportunities Fund doubles down on a buyback strategy. Can $100M succeed where a previous program struggled?